Get startedLog in
    Picture of Veracyte logo

    VCYT — Veracyte News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Veracyte Announces Prelim Full-Year 2023 Results,

    Picture of Veracyte logoVeracyte
    08/01/2024 18:14
    Jan 8 (Reuters) - Veracyte Inc  VCYT.O :
    * VERACYTE ANNOUNCES PRELIMINARY FULL-YEAR 2023 RESULTS,
ACQUISITION OF C2I GENOMICS TO ADD MINIMAL RESIDUAL DISEASE
CAPABILITIES TO ITS NOVEL DIAGNOSTICS PLATFORM
    * SEES Q4 2023 REVENUE OF BETWEEN $95 MILLION AND $96
MILLION, AN
INCREASE OF BETWEEN 18% AND 20%

Source text for Eikon:  ID:nBw5Djw0ra 
Further company coverage:  VCYT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Veracyte

    See all news